Asia Vital Components Crecimiento futuro
Future controles de criterios 6/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Asia Vital Components de 30.2% y 25.3% por año respectivamente. Se prevé que el BPA crezca en un 30.1% al año. Se espera que la rentabilidad financiera sea de 35.3% en 3 años.
Información clave
30.2%
Tasa de crecimiento de los beneficios
30.1%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Tech | 18.4% |
Tasa de crecimiento de los ingresos | 25.3% |
Rentabilidad financiera futura | 35.3% |
Cobertura de analistas | Good |
Última actualización | 14 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Results: Asia Vital Components Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 17Analysts Are Updating Their Asia Vital Components Co., Ltd. (TWSE:3017) Estimates After Its First-Quarter Results
Aug 13Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 17Recent updates
Results: Asia Vital Components Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 17A Look At The Fair Value Of Asia Vital Components Co., Ltd. (TWSE:3017)
Nov 03Asia Vital Components Co., Ltd. (TWSE:3017) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable
Oct 18Is Now The Time To Put Asia Vital Components (TWSE:3017) On Your Watchlist?
Oct 14Is Asia Vital Components (TWSE:3017) A Risky Investment?
Sep 28Analysts Are Updating Their Asia Vital Components Co., Ltd. (TWSE:3017) Estimates After Its First-Quarter Results
Aug 13Asia Vital Components Co., Ltd.'s (TWSE:3017) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors
Aug 06Is Asia Vital Components Co., Ltd. (TWSE:3017) Worth NT$634 Based On Its Intrinsic Value?
Jul 22Asia Vital Components (TWSE:3017) Is Investing Its Capital With Increasing Efficiency
Jul 04Asia Vital Components Co., Ltd.'s (TWSE:3017) P/E Is Still On The Mark Following 30% Share Price Bounce
May 29We Think Asia Vital Components (TWSE:3017) Can Manage Its Debt With Ease
May 21Do Asia Vital Components' (TWSE:3017) Earnings Warrant Your Attention?
Apr 17A Look At The Intrinsic Value Of Asia Vital Components Co., Ltd. (TWSE:3017)
Apr 03Impressive Earnings May Not Tell The Whole Story For Asia Vital Components (TWSE:3017)
Mar 21Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 17Market Participants Recognise Asia Vital Components Co., Ltd.'s (TWSE:3017) Earnings Pushing Shares 29% Higher
Feb 26Is Now The Time To Look At Buying Asia Vital Components Co., Ltd. (TPE:3017)?
Apr 23Does Asia Vital Components (TPE:3017) Have A Healthy Balance Sheet?
Apr 08Asia Vital Components Co., Ltd.'s (TPE:3017) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?
Mar 21Will The ROCE Trend At Asia Vital Components (TPE:3017) Continue?
Feb 16Asia Vital Components Co., Ltd.'s (TPE:3017) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Feb 01Did You Participate In Any Of Asia Vital Components' (TPE:3017) Fantastic 223% Return ?
Jan 17Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 115,928 | 14,593 | 14,511 | 14,953 | 7 |
12/31/2025 | 96,359 | 11,586 | 10,432 | 14,021 | 13 |
12/31/2024 | 71,310 | 8,337 | 6,535 | 10,050 | 10 |
9/30/2024 | 67,577 | 7,506 | 8,746 | 12,826 | N/A |
6/30/2024 | 64,281 | 6,608 | 10,463 | 13,535 | N/A |
3/31/2024 | 62,669 | 5,862 | 9,416 | 12,594 | N/A |
12/31/2023 | 59,194 | 5,305 | 6,556 | 10,324 | N/A |
9/30/2023 | 57,251 | 4,715 | 4,935 | 8,918 | N/A |
6/30/2023 | 56,365 | 4,528 | 3,682 | 8,120 | N/A |
3/31/2023 | 55,258 | 4,423 | 4,358 | 8,612 | N/A |
12/31/2022 | 56,017 | 4,162 | 5,135 | 8,840 | N/A |
9/30/2022 | 53,452 | 3,792 | 3,312 | 6,298 | N/A |
6/30/2022 | 50,342 | 3,407 | 2,133 | 4,482 | N/A |
3/31/2022 | 49,327 | 3,106 | 1,774 | 3,727 | N/A |
12/31/2021 | 47,333 | 2,901 | 1,213 | 2,841 | N/A |
9/30/2021 | 45,646 | 2,704 | 2,026 | 4,261 | N/A |
6/30/2021 | 43,922 | 2,490 | 2,364 | 4,768 | N/A |
3/31/2021 | 42,778 | 2,262 | 1,029 | 3,626 | N/A |
12/31/2020 | 39,666 | 1,916 | 2,404 | 4,870 | N/A |
9/30/2020 | 39,361 | 1,690 | 2,950 | 4,833 | N/A |
6/30/2020 | 39,228 | 1,308 | 1,491 | 3,318 | N/A |
3/31/2020 | 37,107 | 972 | 2,185 | 3,816 | N/A |
12/31/2019 | 36,534 | 958 | 757 | 2,458 | N/A |
9/30/2019 | 34,258 | 871 | -648 | 971 | N/A |
6/30/2019 | 31,962 | 800 | 327 | 1,905 | N/A |
3/31/2019 | 29,482 | 747 | 274 | 1,719 | N/A |
12/31/2018 | 29,067 | 711 | -723 | 971 | N/A |
9/30/2018 | 28,673 | 717 | 122 | 1,635 | N/A |
6/30/2018 | 27,873 | 776 | N/A | 940 | N/A |
3/31/2018 | 27,178 | 811 | N/A | 1,609 | N/A |
12/31/2017 | 27,109 | 887 | N/A | 1,806 | N/A |
9/30/2017 | 26,750 | 930 | N/A | 1,684 | N/A |
6/30/2017 | 26,496 | 898 | N/A | 1,961 | N/A |
3/31/2017 | 26,528 | 869 | N/A | 1,230 | N/A |
12/31/2016 | 26,504 | 860 | N/A | 2,154 | N/A |
9/30/2016 | 26,040 | 826 | N/A | 3,340 | N/A |
6/30/2016 | 26,312 | 829 | N/A | 3,133 | N/A |
3/31/2016 | 26,194 | 797 | N/A | 3,080 | N/A |
12/31/2015 | 25,675 | 741 | N/A | 2,493 | N/A |
9/30/2015 | 25,023 | 681 | N/A | 1,124 | N/A |
6/30/2015 | 24,317 | 822 | N/A | 1,898 | N/A |
3/31/2015 | 24,336 | 820 | N/A | 2,021 | N/A |
12/31/2014 | 24,047 | 729 | N/A | 1,962 | N/A |
9/30/2014 | 23,739 | 640 | N/A | 2,369 | N/A |
6/30/2014 | 22,767 | 355 | N/A | 913 | N/A |
3/31/2014 | 21,397 | 282 | N/A | 1,984 | N/A |
12/31/2013 | 19,990 | 246 | N/A | 1,505 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (30.2% al año) de 3017 es superior a la tasa de ahorro (1.1%).
Beneficios vs. Mercado: Se prevé que los beneficios (30.2% al año) de 3017 crezcan más rápidamente que el mercado TW (19.4% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de 3017 crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (25.3% al año) de 3017 crezcan más rápidamente que los del mercado TW (12.6% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos (25.3% al año) de 3017 crezcan más rápidamente que un 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de 3017 sea alta dentro de 3 años (35.3%)